1 study found for:    s1115
Show Display Options
Rank Status Study
1 Completed
Has Results
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage IV Pancreatic Cancer
Interventions: Drug: Akt Inhibitor MK2206;   Drug: Fluorouracil;   Drug: Oxaliplatin;   Drug: Selumetinib

Indicates status has not been verified in more than two years